Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
Abstract
Adoptively transferred chimeric antigen receptor T cells have stable stem cell–like persistence for at least a decade and more than 500 years of patient safety.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 02, 2012
- Source ID
- 10.1126/scitranslmed.3003761
Entities
People
- Ashley N. Vogel
- Bruce L. Levine
- Carl H. June
- Frederic D. Bushman
- Gabriela Plesa
- Gwendolyn Binder-scholl
- James L. Riley
- John Scholler
- Kristen M. Hege
- Michael Kalos
- Naomi E. Aronson
- Ronald T. Mitsuyasu
- Steven G Deeks
- Troy L. Brady
- Wei-ting Hwang
- Wendy B. Bernstein
Organizations
- Celgene
- Uniformed Services University of the Health Sciences
- University of California, Los Angeles
- University of California, San Francisco
- University of Pennsylvania
- Walter Reed National Military Medical Center